| ASSET | QUARTER | % RETURN |
|---|---|---|
JJill (JILL) | Q1 2017 | 7,882,500% |
AquaBounty Technologies (AQB) | Q1 2017 | 153,788.89% |
Pulmatrix (PULM) | Q1 2017 | 523.21% |
Duos Technologies (DUOT) | Q1 2017 | 499.63% |
Castellum (CTM) | Q1 2017 | 359.86% |
Opus Genetics (IRD) | Q1 2017 | 244.59% |
Aurinia Pharmaceuticals (AUPH) | Q1 2017 | 242.99% |
Pulse Biosciences (PLSE) | Q1 2017 | 214% |
OLB (OLB) | Q1 2017 | 200% |
Protalix Biotherapeutics (PLX) | Q1 2017 | 183.27% |
TSS, Inc Common Stock (TSSI) | Q1 2017 | 182.5% |
Esperion Therapeutics (ESPR) | Q1 2017 | 175.86% |
Quoin Pharmaceuticals Ltd DRC (QNRX) | Q1 2017 | 169.59% |
Quantum Computing (QUBT) | Q1 2017 | 150% |
authID (AUID) | Q1 2017 | 150% |
Cenntro Electric (CENN) | Q1 2017 | 147.42% |
TG Therapeutics (TGTX) | Q1 2017 | 142.71% |
Sanara Medtech (SMTI) | Q1 2017 | 139.47% |
Galectin Therapeutics (GALT) | Q1 2017 | 137.11% |
Applied Opt (AAOI) | Q1 2017 | 136.82% |
Oncolytics Biotech (ONCY) | Q1 2017 | 133.05% |
LifeMD (LFMD) | Q1 2017 | 127.27% |
Freedom (FRHC) | Q1 2017 | 127.27% |
Star Bulk Carriers (SBLK) | Q1 2017 | 126.71% |
Viridian Therapeutics (VRDN) | Q1 2017 | 126.28% |
